Burkehill Global Management »

Maplight Therapeutics shares owned by Burkehill Global Management

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Burkehill Global Management from 13F filings

Historical chart of Burkehill Global Management investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Burkehill Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Burkehill Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 75k 17.57

More positions owned by Burkehill Global Management

Itt (ITT)
Sofi Technologies (SOFI)
Nasdaq Omx (NDAQ)
Lauder Estee Cos Cl A (EL)
Coreweave Com Cl A (CRWV)
Rollins (ROL)
Standardaero (SARO)
Medline Com Cl A (MDLN)
Realty Income (O)
Galaxy Digital Cl A (GLXY)
Figure Technology Solutio Com Cl A (FIGR)
Viking Holdings Ord Shs (VIK)
Symbotic Class A Com (SYM)
Nebius Group Shs Class A (NBIS)
Loar Holdings Com Shs (LOAR)

View all positions for Burkehill Global Management

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital
Jain Global

View all funds holding Maplight Therapeutics